Immune pathway through endometriosis to ovarian cancer

Article Properties
  • Publication Date
    2024/04/24
  • Indian UGC (journal)
  • Refrences
    302
  • Mariana Santos Calmon
  • Fabian Fellipe Bueno Lemos
  • Marcel Silva Luz
  • Samuel Luca Rocha Pinheiro
  • Luis Guilherme de Oliveira Silva
  • Gabriel Lima Correa Santos
  • Gabriel Reis Rocha
  • Fabrício Freire de Melo
Abstract
Cite
Calmon, Mariana Santos, et al. “Immune Pathway through Endometriosis to Ovarian Cancer”. World Journal of Clinical Oncology, vol. 15, no. 4, 2024, pp. 496-22, https://doi.org/10.5306/wjco.v15.i4.496.
Calmon, M. S., Lemos, F. F. B., Silva Luz, M., Rocha Pinheiro, S. L., de Oliveira Silva, L. G., Correa Santos, G. L., Rocha, G. R., & Freire de Melo, F. (2024). Immune pathway through endometriosis to ovarian cancer. World Journal of Clinical Oncology, 15(4), 496-522. https://doi.org/10.5306/wjco.v15.i4.496
Calmon, Mariana Santos, Fabian Fellipe Bueno Lemos, Marcel Silva Luz, Samuel Luca Rocha Pinheiro, Luis Guilherme de Oliveira Silva, Gabriel Lima Correa Santos, Gabriel Reis Rocha, and Fabrício Freire de Melo. “Immune Pathway through Endometriosis to Ovarian Cancer”. World Journal of Clinical Oncology 15, no. 4 (2024): 496-522. https://doi.org/10.5306/wjco.v15.i4.496.
Calmon MS, Lemos FFB, Silva Luz M, Rocha Pinheiro SL, de Oliveira Silva LG, Correa Santos GL, et al. Immune pathway through endometriosis to ovarian cancer. World Journal of Clinical Oncology. 2024;15(4):496-522.
Journal Category
Medicine
Internal medicine
Neoplasms
Tumors
Oncology
Including cancer and carcinogens
Refrences
Title Journal Journal Categories Citations Publication Date
Decreased Bcl-6 and increased Blimp-1 in the peritoneal cavity of patients with endometriosis Clinical and Experimental Obstetrics & Gynecology
  • Medicine: Gynecology and obstetrics
  • Medicine: Gynecology and obstetrics
  • Medicine
  • Medicine: Medicine (General)
14 2015
10.1016/S0015-0282(16)58262-4
10.1016/S0021-9258(17)35666-1
10.1182/blood.V87.12.5257.bloodjournal87125257
Soluble Ligands for the NKG2D Receptor Are Released during Endometriosis and Correlate with Disease Severity PLOS ONE
  • Medicine
  • Science
  • Science: Science (General)
26 2015